Timothy A. Coleman
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms 9
- NF-κB Signaling Pathways 4
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms 5
- Immunology top 10%
- interferon and immune responses 3
- Neurology top 5%
- Cell Biology top 5%
-
- Virus-based gene therapy research 5
-
- RNA Interference and Gene Delivery 4
- Biochemical and Molecular Research 3
- Viral Infectious Diseases and Gene Expression in Insects 3
- Co-authors
- Daniel A. LawrenceMaria SandkvistManuel YepesElizabeth SmithC A RosenStanley CohanSteven M. RubenElizabeth Moore
- Cited by
- Cancer ResearchHematologyImmunology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (5 papers)Circulation (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Timothy A. Coleman
33 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 748
- Hematology 256
- Immunology 425
- Neurology 151
- Cell Biology 259
Countries citing papers authored by Timothy A. Coleman
This map shows the geographic impact of Timothy A. Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy A. Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy A. Coleman more than expected).
Fields of papers citing papers by Timothy A. Coleman
This network shows the impact of papers produced by Timothy A. Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy A. Coleman. The network helps show where Timothy A. Coleman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Timothy A. Coleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 111 | |
| 2 | 2002 | 26 | |
| 3 | 2002 | 119 | |
| 4 | 2001 | 46 | |
| 5 | 2001 | 211 | |
| 6 | 2000 | 74 | |
| 7 | 2000 | 229 | |
| 8 | 1997 | 6 | |
| 9 | 1997 | 14 | |
| 10 | 1997 | 28 | |
| 11 | 1997 | 147 | |
| 12 | 1997 | 192 | |
| 13 | 1995 | 2 | |
| 14 | 1993 | 81 | |
| 15 | The SV40 early transcriptional regulatory element is unable to direct gene expression in pituitary GH-3 cells. | 1992 | 7 |
| 16 | 1991 | 2 | |
| 17 | 1991 | 7 | |
| 18 | 1990 | 5 | |
| 19 | 1985 | 17 | |
| 20 | 1985 | 39 |
About Timothy A. Coleman
Timothy A. Coleman is a scholar working on Cancer Research, Hematology and Biochemistry, having authored 33 papers that have together received 2.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Virus-based gene therapy research (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), RNA Interference and Gene Delivery (4 papers), NF-κB Signaling Pathways (4 papers), interferon and immune responses (3 papers), Biochemical and Molecular Research (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). The work is most often cited by research in Cancer Research (748 citations), Hematology (256 citations) and Immunology (425 citations). Timothy A. Coleman has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Daniel A. Lawrence, Maria Sandkvist, Manuel Yepes, Elizabeth Smith, C A Rosen, Stanley Cohan, Steven M. Ruben, Elizabeth Moore, Maureen Maher and Herbert Weissbach. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.